December 14, 2021
Dear Advocate,
We are delighted to share the next installment in our
Px Pulse podcast series
Research Fundamentals, explaining key concepts in HIV prevention research.
In this episode,
Px Pulse host Jeanne Baron, and Matthew Rose, veteran HIV advocate and Director at Global Health Strategies, unpack what you need to know to understand
endpoints in research.
Our series,
Research Fundamentals is an addition to the regular schedule of programs on
Px Pulse covering advances and challenges in HIV prevention research.
Research Fundamentals offers short, concise and accessible conversations explaining scientific concepts in research that are key to understanding how HIV prevention science is advancing.
Endpoints are a crucial component in every clinical trial, but they are not always well understood. In addition, advocates can and should play a role, reviewing endpoints and interrogating how well the trial will serve communities that need HIV prevention.
Joining us to explore all this are:
- Dave Glidden, Professor of Epidemiology & Bio-statistics at UC San Francisco
- Erica Lessem, Senior Strategist for the New York City Department of Health and Mental Hygiene, former Deputy Executive Director, Treatment Action Group
- Meagan O’Brien, Senior Medical Director of Early Clinical Development & Clinical Experimental Sciences at Regeneron
Listen to the full podcast (9 minutes) to learn how endpoints are used in clinical research, why they change over time, and what matters most about endpoints for advocates and researchers alike. And here’s a
transcript of the recording.
Endpoints are one element in evolving trial design for HIV prevention. Go to our
dedicated page on trial design for more information and resources to engage with this fast-changing area.
Happy Listening,
AVAC
